Health Canada
Symbol of the Government of Canada
Consumer Product Safety

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2008-2498

2. Registrant Information.

Registrant Reference Number: Prosar case 1-16111103

Registrant Name (Full Legal Name no abbreviations): FMC Corporation

Address: 1735 Market Street

City: Philadelphia

Prov / State: Pennsylvania

Country: USA

Postal Code: 19103

3. Select the appropriate subform(s) for the incident.

Domestic Animal

4. Date registrant was first informed of the incident.


5. Location of incident.



6. Date incident was first observed.


Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.


PMRA Registration No.       PMRA Submission No.       EPA Registration No. 279-3062

Product Name: Dragnet SFR Termiticide/Insecticide

  • Active Ingredient(s)
      • Guarantee/concentration 36.8 %

7. b) Type of formulation.


Application Information

8. Product was applied?


9. Application Rate.


10. Site pesticide was applied to (select all that apply).

Site: Res. - In Home / Rés. - à l'int. maison

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

The product was applied by a pesticide company to the inside perimeter of a rented house on 4/7/08.

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?


Subform III: Domestic Animal Incident Report

1. Source of Report


2. Type of animal affected

Cat / Chat

3. Breed


4. Number of animals affected


5. Sex


6. Age (provide a range if necessary )


7. Weight (provide a range if necessary )


8. Route(s) of exposure


9. What was the length of exposure?

Unknown / Inconnu

10. Time between exposure and onset of symptoms

Unknown / Inconnu

11. List all symptoms


  • General
    • Symptom - Abnormal behaviour
    • Specify - Not acting right
  • Nervous and Muscular Systems
    • Symptom - Collapse
    • Symptom - Unresponsive
    • Specify - Non-responsive
  • Gastrointestinal System
    • Symptom - Other
    • Specify - Digestive system "was failing"
  • General
    • Symptom - Death

12. How long did the symptoms last?

Persisted until death

13. Was medical treatment provided? Provide details in question 17.


14. a) Was the animal hospitalized?


14. b) How long was the animal hospitalized?

15. Outcome of the incident


16. How was the animal exposed?

Other / Autre

specify Unknown exposure, cat was outside during spraying and came into the house "a while" after spraying had been completed

17. Provide any additional details about the incident

(eg. description of the frequency and severity of the symptoms

1-16111103: The reporter, a pest control officer, called on 5/6/08 to report a client had contacted him with the claim that her pregnant cat had died as a result of exposure to a product containing the active ingredient Permethrin. The product had been applied on 4/7/08 to the inside perimeter of a rented house, while the resident's cat had been outside. The resident had been told to keep the cat out of the house during spraying, as well as for a while afterward. The reporter was unsure if the product had dried by the time the cat had re-entered the dwelling. According to the owner, the cat had been allowed back in "a while" after the product had been sprayed. The owner had then consulted a veterinarian over the phone, as the cat had not acted normally upon re-entry. Per the veterinarian's advice, the owner had given the cat milk. After the cat had drunk the milk, she had fallen over and become non-responsive. The owner had then taken the cat to the veterinarian for evaluation, who determined the cat¿¿¿s digestive system ¿¿¿was failing¿¿? ¿¿¿ possibly from exposure to a toxin. The cat had subsequently passed away. The reporter inquired about the safety profile of the product, which was discussed. Assuming the product had been properly diluted, GI or dermal irritation may have been seen with an exposure. However, neurological symptoms would not be expected.

To be determined by Registrant

18. Severity classification (if there is more than 1 possible classification


19. Provide supplemental information here